Finance

Lists
S1YK34:BVMF
Stryker Corp Bdr
R$69,24
0,00%
(0,00) 1D
7 Okt., 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for S1YK34...
Open
R$69,96
High
R$70,00
Low
R$69,24
Mkt. cap
105,64 mjd
Avg. vol.
3,51 k
Volume
303,00
52-wk high
R$101,65
52-wk low
R$67,62
Shares outstanding
383,57 m
No. of employees
56 k
Open
R$69,96
High
R$70,00
Low
R$69,24
Mkt. cap
105,64 mjd
Avg. vol.
3,51 k
Volume
303,00
52-wk high
R$101,65
52-wk low
R$67,62
Shares outstanding
383,57 m
No. of employees
56 k
News stories
From web sources and news partners
Profile
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States. The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000. Wikipedia
About Stryker Corp Bdr
CEOKevin A. Lobo
Employees56 k
Founded1941
HeadquartersKalamazoo, Michigan, Verenigde State van Amerika
SectorMedical device
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
6,06 mjd
7,17 mjd
6,02 mjd
6,59 mjd
Cost of goods sold
2,12 mjd
2,49 mjd
2,19 mjd
2,08 mjd
Cost of revenue
2,12 mjd
2,49 mjd
2,19 mjd
2,08 mjd
Research and development expenses
409,00 m
388,00 m
409,00 m
429,00 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,99 mjd
2,15 mjd
2,16 mjd
2,13 mjd
Operating expense
2,58 mjd
2,72 mjd
2,75 mjd
2,73 mjd
Total operating expenses
4,71 mjd
5,22 mjd
4,95 mjd
4,81 mjd
Operating income
1,35 mjd
1,95 mjd
1,07 mjd
1,78 mjd
Other non operating income
-138,00 m
420,00 m
19,00 m
1,00 m
EBT including unusual items
1,03 mjd
1,70 mjd
850,00 m
1,56 mjd
EBT excluding unusual items
1,25 mjd
1,81 mjd
987,00 m
1,68 mjd
Income tax expense
170,00 m
856,00 m
105,00 m
288,00 m
Effective tax rate
16,52%
50,21%
12,35%
18,41%
Other operating expenses
-
-
-
-
Net income
859,00 m
849,00 m
745,00 m
1,28 mjd
Net profit margin
14,18%
11,84%
12,38%
19,37%
Earnings per share
3,19
4,47
2,60
3,69
Interest and investment income
28,00 m
31,00 m
34,00 m
26,00 m
Interest expense
-
-607,00 m
-148,00 m
-141,00 m
Net interest expenses
28,00 m
-576,00 m
-114,00 m
-115,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
1,66 mjd
2,27 mjd
1,37 mjd
2,08 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme